{
  "zip": "94104",
  "sector": "Healthcare",
  "longBusinessSummary": "Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.",
  "city": "San Francisco",
  "phone": "415-869-1036",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.oncology-pharma.com",
  "maxAge": 1,
  "address1": "1 Sansome Street",
  "fax": "415-946-8801",
  "industry": "Biotechnology",
  "address2": "Suite 3500",
  "previousClose": 0.457,
  "regularMarketOpen": 0.422,
  "twoHundredDayAverage": 0.24193294,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.457,
  "navPrice": null,
  "averageDailyVolume10Day": 1065,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.457,
  "fiftyDayAverage": 0.4990712,
  "trailingAnnualDividendRate": null,
  "open": 0.422,
  "averageVolume10days": 1065,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -2.931197,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.457,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 651,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 756682,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 946,
  "priceToSalesTrailing12Months": 74.082825,
  "dayLow": 0.457,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 651,
  "fiftyTwoWeekHigh": 1.55,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.00395,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.457,
  "exchange": "PNK",
  "shortName": "ONCOLOGY PHARMA INC",
  "longName": "Oncology Pharma Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ONPH",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_407420",
  "uuid": "d8b90fcb-6d92-31ae-998b-804f2487f580",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 18.21373,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 1164120,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": 0,
  "sharesPercentSharesOut": 0,
  "fundFamily": null,
  "lastFiscalYearEnd": 1364688000,
  "heldPercentInstitutions": null,
  "netIncomeToCommon": -15269,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": null,
  "nextFiscalYearEnd": 1427760000,
  "mostRecentQuarter": 1325289600,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": 1018396800,
  "floatShares": null,
  "enterpriseValue": null,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1602201600,
  "lastSplitFactor": "1:100",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1023753600,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": 0,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.422,
  "logo_url": "https://logo.clearbit.com/oncology-pharma.com"
}